Oxford scientists probe Serotonin's secret switch in healthy brains
NCT ID NCT07022366
First seen May 08, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study at the University of Oxford looks at how a drug called pimavanserin, which blocks a specific serotonin receptor in the brain, affects memory, emotions, and decision-making. Researchers will compare the drug to a placebo in 80 healthy adults aged 18-45. The goal is to better understand this brain receptor, which could help develop new treatments for depression in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Psychiatry, University of Oxford
RECRUITINGOxford, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.